A New Promising Anti-Infective Agent Inhibits Biofilm Growth by Targeting Simultaneously a Conserved RNA Function That Controls Multiple Genes
Posted by Adam Awdish on
Pooled Human Plasma (Blood Derived) from Innovative Research was used in the following study:
Thorsten M. Seyler, Christina Moore, Haein Kim, Sheetal Ramachandran and Paul F. Agris
Antibiotics
January 4, 2021
An immediate contemporary challenge in the field of medicine is that of combating drug-resistant infections in the form of biofilms. Due to the diverse population of bacteria that can cause infection and their constantly evolving defense mechanisms, there is a lot of focus on developing new treatments that are both effective on current known infections as well as prevent the emergence of new strains of infection. In this study, researchers investigated PKZ18-22, an analog to commonly used antibiotic that boasts 10x the potency, to better understand its mechanisms of action and potential for therapeutic use.
Related products available from Innovative Research also include:
Single Donor Human Plasma (Blood Derived)